Can systemic illness, inflammation, impaired liver function, and metabolic dysfunction reduce T4 to T3 conversion and increase thyroid hormone inactivation?

Thyroid-hormone activation and disposal are dynamically altered during illness, particularly in older adults in whom systemic disease, liver dysfunction, and dysglycemia commonly overlap. The resulting low-T3/high-rT3 pattern is characteristic of nonthyroidal illness rather than, by itself, primary hypothyroidism.

Clinical and biochemical evidence

• Systemic illness and inflammation can reduce peripheral T4-to-T3 conversion, producing lower circulating T3 and often higher reverse T3 (rT3). This is linked to reduced hepatic type 1 deiodinase (D1) activity, reduced rT3 clearance, and altered tissue-specific deiodinase activity.
• Significant hepatic dysfunction, especially cirrhosis, is associated with reduced DIO1 activity/expression, lower T3, higher rT3, and declining T3/rT3 ratios. The liver is a major site for extrathyroidal thyroid-hormone metabolism.
• Metabolic dysfunction is less consistent: established diabetes or hyperglycemia has been associated with impaired hepatic conversion, whereas early insulin resistance has sometimes been associated with higher FT3/FT4 ratios.

Mechanisms

• Inflammatory signaling has direct mechanistic support. Human IL-6 administration transiently lowered serum T3 and raised rT3; cellular data indicate IL-6 can suppress D1/D2-mediated T4 activation while promoting D3-mediated inactivation.
• Type 3 deiodinase (D3) performs inner-ring deiodination, converting T4 to inactive rT3 and T3 to inactive T2. Thus, reduced activation and increased inactivation can jointly reduce active-T3 availability.
• Liver disease may also alter sulfation, glucuronidation, biliary handling, and clearance of iodothyronine metabolites.

Clinical interpretation

• Low T3 or elevated rT3 should not alone be interpreted as primary thyroid failure: illness severity, nutrition, medications, altered binding, hepatic uptake, and impaired rT3 clearance contribute to these values.

Bottom line

• The claim is supported, most strongly for systemic illness, inflammation, and substantial liver dysfunction; metabolic dysfunction is biologically plausible but less uniformly established.